851314-56-2 Usage
Molecular Weight
287.28 g/mol
Benzyl group
A phenyl group attached to a carbon atom in the molecule.
Piperidine ring
A six-membered nitrogen-containing ring structure.
Fluorine atoms
Two fluorine atoms present in the molecule.
Carboxylic acid group
A functional group consisting of a carbonyl (C=O) and a hydroxyl (-OH) group attached to the same carbon atom.
Ethyl ester functional group
An ester formed by the reaction of a carboxylic acid and an alcohol, in this case, ethyl alcohol.
Appearance
Likely a solid or oily liquid, depending on the conditions.
Solubility
Soluble in organic solvents like ethanol, methanol, and dichloromethane.
Reactivity
Can undergo reactions typical of esters, such as hydrolysis and transesterification.
Stability
Relatively stable under normal conditions, but sensitive to strong acids, bases, and nucleophiles.
Medicinal Chemistry
Potential use in the development of pharmaceutical drugs due to its unique structure and potential biological activity.
Organic Synthesis
Can be used as a building block for creating other complex compounds.
Hazards
Potential irritant or toxic, depending on the dose and exposure route.
Precautions
Handle in a well-ventilated area and use appropriate personal protective equipment (PPE), such as gloves and safety goggles.
Check Digit Verification of cas no
The CAS Registry Mumber 851314-56-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,1,3,1 and 4 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 851314-56:
(8*8)+(7*5)+(6*1)+(5*3)+(4*1)+(3*4)+(2*5)+(1*6)=152
152 % 10 = 2
So 851314-56-2 is a valid CAS Registry Number.
851314-56-2Relevant articles and documents
5-SUBSTITUTED DIFLUOROPIPERIDINE COMPOUND CAPABLE OF PASSING THROUGH BLOOD-BRAIN BARRIER
-
, (2021/02/18)
The present invention discloses 5-substituted difluoropiperidine compounds having a capacity to cross the blood-brain barrier; the compound has the structural formula represented by formula (I): The 5-substituted difluoropiperidine compounds, derivatives
Quinazoline derivative salt-type crystal forms and preparation method and application thereof
-
, (2019/10/29)
The invention discloses quinazoline derivative salt-type crystal forms and a preparation method and application thereof. The quinazoline derivative salt-type crystal forms are specifically the hydrochloride crystal forms A, B, C, D, F, H, I, the sulphate
FATTY ACID SYNTHASE INHIBITORS
-
, (2014/01/18)
This invention relates to novel spirocyclic piperidines according to Formula (I) which are inhibitors of fatty acid synthase (FAS), to pharmaceutical compositions containing them, to processes for their preparation, and to their use in therapy for the treatment of cancers.